 |
Acorda Therapeutics
ACOR
|
13.5 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 |
- |
- |
$ 86.2 M |
USA |
 |
MorphoSys AG
MOR
|
18.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 |
$ 3.73 |
- |
$ 8.97 B |
Australia |
 |
Akouos
AKUS
|
5.34 |
- |
0.23 % |
$ 488 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
311 |
$ 333.39 |
- |
$ 43.7 B |
USA |
 |
Applied Molecular Transport
AMTI
|
0.57 |
- |
- |
$ 10.1 M |
USA |
 |
I-Mab
IMAB
|
0.68 |
- |
- |
$ 866 M |
China |
 |
AlloVir
ALVR
|
9.78 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Burford Capital Limited
BUR
|
10.6 |
$ 4.73 |
- |
$ 784 M |
Britain |
 |
Cabaletta Bio
CABA
|
2.82 |
$ 3.4 |
- |
$ 342 M |
USA |
 |
Genfit SA
GNFT
|
3.36 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
0.33 |
- |
-13.47 % |
$ 169 M |
France |
 |
Aligos Therapeutics
ALGS
|
6.67 |
$ 7.42 |
- |
$ 73.3 M |
USA |
 |
Allakos
ALLK
|
1.31 |
- |
- |
$ 28.6 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 |
$ 3.17 |
- |
$ 5.22 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 |
- |
- |
$ 7.46 M |
Israel |
 |
Midatech Pharma plc
MTP
|
0.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Applied Therapeutics
APLT
|
6.42 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
0.14 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
1.66 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
CNS Pharmaceuticals
CNSP
|
2.39 |
$ 2.75 |
4.16 % |
$ 1.22 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 |
$ 21.68 |
- |
$ 1.01 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
32.3 |
- |
- |
$ 3.45 B |
USA |
 |
BioNTech SE
BNTX
|
91.2 |
$ 99.47 |
- |
$ 27.2 B |
Germany |
 |
Advaxis
ADXS
|
0.31 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
5.72 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
13 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
ContraFect Corporation
CFRX
|
2.07 |
- |
-5.16 % |
$ 5.39 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.3 |
$ 1.55 |
- |
$ 399 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
4.37 |
$ 4.24 |
- |
$ 453 M |
USA |
 |
Galectin Therapeutics
GALT
|
2.79 |
$ 2.56 |
- |
$ 164 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 |
$ 24.58 |
- |
$ 3.13 B |
USA |
 |
AIkido Pharma
AIKI
|
3.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Genmab A/S
GMAB
|
33.5 |
$ 29.3 |
- |
$ 18.8 B |
Danmark |
 |
Autolus Therapeutics plc
AUTL
|
1.21 |
$ 1.49 |
- |
$ 397 M |
Britain |
 |
Aptose Biosciences
APTO
|
3.32 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
185 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Checkpoint Therapeutics
CKPT
|
4.04 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
0.43 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Celldex Therapeutics
CLDX
|
30.7 |
$ 33.87 |
- |
$ 2.25 B |
USA |
 |
AVROBIO
AVRO
|
1.27 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Clearside Biomedical
CLSD
|
1.64 |
- |
- |
$ 25.3 M |
USA |